Astrana Health Forecast, price target & analysts
Astrana Health Target price 2026 - Analyst rating & recommendation
Astrana Health Classifications & Recommendation
Astrana Health Price Target
| Target Price | $51.00 |
| Price | $36.37 |
| Potential |
40.23%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Astrana Health 2027 .
The average Astrana Health target price is $51.00.
This is
40.23%
register free of charge
$68.25
87.65%
register free of charge
$41.41
13.86%
register free of charge
|
|
| A rating was issued by 16 analysts: 14 Analysts recommend Astrana Health to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Astrana Health stock has an average upside potential 2027 of
40.23%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.18 | 4.06 |
| 56.39% | 27.57% | |
| EBITDA Margin | 4.52% | 6.76% |
| 21.56% | 49.50% | |
| Net Margin | 0.71% | 1.71% |
| 66.67% | 141.92% |
12 Analysts have issued a sales forecast Astrana Health 2026 . The average Astrana Health sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Astrana Health EBITDA forecast 2026. The average Astrana Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Astrana Health Analysts have issued a net profit forecast 2026. The average Astrana Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.46 | 1.41 |
| 48.89% | 206.52% | |
| P/E | 25.74 | |
| EV/Sales | 0.58 |
12 Analysts have issued a Astrana Health forecast for earnings per share. The average Astrana Health EPS is
This results in the following potential growth metrics and future valuations:
Current Astrana Health Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Oppenheimer |
Locked
➜
Locked
|
Locked | Sep 15 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jul 14 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Jul 14 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | May 26 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Sep 15 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 14 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Jul 14 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
May 26 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
